Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments

Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments

Bibliographic Details
Main Authors:	Alejandro Ramírez-Chacón, Sergi Betriu-Méndez, Ariadna Bartoló-Ibars, Azucena González, Mercè Martí, Manel Juan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Immunology
Subjects:	T cells chimeric antigen receptor (CAR) ligands receptor antigen CAAR
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/full

Similar Items

Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments
by: Alejandro Ramírez-Chacón, et al.
Published: (2022-09-01)

T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01)

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
by: Marta Włodarczyk, et al.
Published: (2022-12-01)

Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
by: Gianna M. Branella, et al.
Published: (2021-12-01)

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
by: Francesco Boccalatte, et al.
Published: (2022-10-01)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
by: Ariadna Bartoló-Ibars, et al.
Published: (2021-09-01)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
by: Ernesto Lopez, et al.
Published: (2023-12-01)

T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors
by: Nicholas J. Chandler, et al.
Published: (2020-10-01)

Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
by: Cihan Taştan, et al.
Published: (2020-11-01)

Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
by: Qiuqiang Chen, et al.
Published: (2022-12-01)

How CAR T Cells Breathe
by: Christopher Forcados, et al.
Published: (2022-04-01)

Corrigendum: Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers
by: Qiang Feng, et al.
Published: (2022-12-01)

Ligand-based adoptive T cell targeting CA125 in ovarian cancer
by: Haihong Zhao, et al.
Published: (2023-09-01)

Gene Targets of CAR-T Cell Therapy for Glioblastoma
by: Chaoqun Wang, et al.
Published: (2023-04-01)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
by: Cristina Aparicio, et al.
Published: (2021-10-01)

Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein
by: Pablo Gonzalez-Garcia, et al.
Published: (2023-04-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
by: Samer A. Srour, et al.
Published: (2023-01-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

Cytopenia after CAR-T Cell Therapy—A Brief Review of a Complex Problem
by: Naman Sharma, et al.
Published: (2022-03-01)

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
by: Ewelina Grywalska, et al.
Published: (2020-04-01)

Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression
by: Wei Jiang, et al.
Published: (2023-11-01)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
by: Piotr Celichowski, et al.
Published: (2023-03-01)

CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
by: Elisabetta Cribioli, et al.
Published: (2022-08-01)

Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023
by: Ming-Yao Sun, et al.
Published: (2023-08-01)

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
by: Giuseppe Schepisi, et al.
Published: (2020-09-01)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
by: Wenwen Wei, et al.
Published: (2022-11-01)

Emerging Novel Combined CAR-T Cell Therapies
by: Anh Nguyen, et al.
Published: (2022-03-01)

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions
by: Norris Lam, et al.
Published: (2023-09-01)

Modular Chimeric Antigen Receptor Systems for Universal CAR T Cell Retargeting
by: Ashley R. Sutherland, et al.
Published: (2020-09-01)

Geometric parameters that affect the behavior of logic-gated CAR T cells
by: Alexander C. Partin, et al.
Published: (2024-01-01)

Most Do, but Some Do Not: CD4+CD25− T Cells, but Not CD4+CD25+ Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR)
by: Andreas A. Hombach, et al.
Published: (2017-08-01)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
by: Kaveh Hadiloo, et al.
Published: (2023-05-01)

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2017-12-01)

Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies
by: Bailu Xie, et al.
Published: (2022-06-01)

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
by: Andriy Zhylko, et al.
Published: (2020-07-01)

Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
by: Carlos Moreno, et al.
Published: (2022-06-01)

Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland
by: Tomasz J. Ślebioda, et al.
Published: (2022-11-01)

Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
by: Hanfei Guo, et al.
Published: (2022-03-01)

CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours
by: Hiu Kwan Carolyn Tang, et al.
Published: (2023-06-01)